Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
La Radiologia Medica
|
December 1, 1978
[Neonatal hypophosphatasia (author's transl)]
C Sandomenico, S Vaccaro, F Caruso, et al.
International Journal of Oncology
|
May 5, 2011
8-chloro-cAMP enhances the growth inhibitory effect of cytotoxic drugs in human colon cancer cells
G Diisernia, F Ciardiello, C Sandomenico, et al.
Cancer Research
|
November 26, 1997
Synergistic inhibition of growth and induction of apoptosis by 8-chloro-cAMP and paclitaxel or cisplatin in human cancer cells
G Tortora, G di Isernia, C Sandomenico, et al.
International Journal of Cancer
|
October 23, 1997
Anti-sense oligonucleotides directed against EGF-related growth factors enhance anti-proliferative effect of conventional anti-tumor drugs in human colon-cancer cells
A De Luca, M P Selvam, C Sandomenico, et al.
Current Medicinal Chemistry
|
January 5, 2012
Bevacizumab in non small cell lung cancer: development, current status and issues
C Sandomenico, R Costanzo, G Carillio, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research
|
November 4, 2000
Retinoic acid induces neuronal differentiation of embryonal carcinoma cells by reducing proteasome-dependent proteolysis of the cyclin-dependent inhibitor p27
G Baldassarre, A Boccia, P Bruni, et al.
Oncogene
|
December 22, 1999
Key role of the cyclin-dependent kinase inhibitor p27kip1 for embryonal carcinoma cell survival and differentiation
G Baldassarre, M V Barone, B Belletti, et al.
Oncogene
|
August 18, 1997
Expression of teratocarcinoma-derived growth factor-1 (TDGF-1) in testis germ cell tumors and its effects on growth and differentiation of embryonal carcinoma cell line NTERA2/D1
G Baldassarre, A Romano, F Armenante, et al.
Cancer
|
August 30, 2000
Nuclear DNA content-derived parameters correlated with heterogeneous expression of p53 and bcl-2 proteins in clear cell renal carcinomas
S Pepe, A Ruggiero, M D'Acquisto, et al.
Drugs of Today (Barcelona, Spain : 1998)
|
October 23, 2010
Vandetanib: An overview of its clinical development in NSCLC and other tumors
A Morabito, M C Piccirillo, R Costanzo, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
La Radiologia Medica
|
December 1, 1978
[Neonatal hypophosphatasia (author's transl)]
C Sandomenico, S Vaccaro, F Caruso, et al.
International Journal of Oncology
|
May 5, 2011
8-chloro-cAMP enhances the growth inhibitory effect of cytotoxic drugs in human colon cancer cells
G Diisernia, F Ciardiello, C Sandomenico, et al.
Cancer Research
|
November 26, 1997
Synergistic inhibition of growth and induction of apoptosis by 8-chloro-cAMP and paclitaxel or cisplatin in human cancer cells
G Tortora, G di Isernia, C Sandomenico, et al.
International Journal of Cancer
|
October 23, 1997
Anti-sense oligonucleotides directed against EGF-related growth factors enhance anti-proliferative effect of conventional anti-tumor drugs in human colon-cancer cells
A De Luca, M P Selvam, C Sandomenico, et al.
Current Medicinal Chemistry
|
January 5, 2012
Bevacizumab in non small cell lung cancer: development, current status and issues
C Sandomenico, R Costanzo, G Carillio, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research
|
November 4, 2000
Retinoic acid induces neuronal differentiation of embryonal carcinoma cells by reducing proteasome-dependent proteolysis of the cyclin-dependent inhibitor p27
G Baldassarre, A Boccia, P Bruni, et al.
Oncogene
|
December 22, 1999
Key role of the cyclin-dependent kinase inhibitor p27kip1 for embryonal carcinoma cell survival and differentiation
G Baldassarre, M V Barone, B Belletti, et al.
Oncogene
|
August 18, 1997
Expression of teratocarcinoma-derived growth factor-1 (TDGF-1) in testis germ cell tumors and its effects on growth and differentiation of embryonal carcinoma cell line NTERA2/D1
G Baldassarre, A Romano, F Armenante, et al.
Cancer
|
August 30, 2000
Nuclear DNA content-derived parameters correlated with heterogeneous expression of p53 and bcl-2 proteins in clear cell renal carcinomas
S Pepe, A Ruggiero, M D'Acquisto, et al.
Drugs of Today (Barcelona, Spain : 1998)
|
October 23, 2010
Vandetanib: An overview of its clinical development in NSCLC and other tumors
A Morabito, M C Piccirillo, R Costanzo, et al.
Page
of 2